CAMDEN, N.J., April 3, 2014 /PRNewswire/ -- Cooper University Health Care recently strengthened patient safety measures by expanding its use of capnography to monitor patients using patient-controlled analgesia (PCA) to regulate their pain after surgery.
PCA can provide an effective way to control pain by allowing patients to self-administer small doses of pain medication intravenously, but the technology poses unique risks because the opioid medications used can also suppress the patient's breathing. The Joint Commission, the Anesthesia Patient Safety Foundation, the Institute for Healthcare Improvement and the Institute for Safe Medication Practices all recommend that hospitals take special precautions including monitoring patients with capnography and oximetry.
Specifically, capnography measures how effectively patients are breathing by measuring exhaled carbon dioxide and can alert medical caregivers when life-threatening respiratory depression occurs. Capnography provides the earliest indication of evolving respiratory compromise, which can lead to significant morbidity or even cardiopulmonary arrest if undetected. Oximetry monitors the patient's blood oxygen levels ensuring that the patient is receiving enough oxygen.
Cooper University Health Care is among the nation's leaders in the early implementation of capnography monitoring to protect patients using PCA. Long used in operating rooms to monitor patients under general anesthesia, hospitals are now deploying capnography after surgery, as well. Early indication of respiratory depression with capnography enables medical staff to intervene before serious adverse events happen.
"Cooper University Health Care is committed to providing the highest quality of care. Our widespread use of capnography to monitor a patient's breathing is in line with the latest recommendations and underscores our dedication to patient safety," said Anthony Mazzarelli, MD, JD, MBE, Senior Vice President of Operations and Chief Medical Officer.
Cooper University Health Care chose capnography equipment from Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices.
"We commend Cooper University Health Care for being part of a growing number of facilities across the country committed to patient safety through the use of capnography," said Matt Anderson, Vice President and General Manager, Respiratory & Monitoring Solutions, Covidien. "Its decision to monitor patients at risk of respiratory depression with capnography and oximetry ensures patients have a level of protection when using state-of-the-art pain management systems."
About Cooper University Health Care
Cooper University Health Care is one of the largest health systems in Southern New Jersey with over 100 outpatient offices and its flagship, Cooper University Hospital located in Camden, NJ. It is the premier university hospital serving South Jersey and the Delaware Valley. Cooper University Hospital is the clinical teaching campus for Cooper Medical School of Rowan University, the only four-year allopathic medical school in South Jersey. Cooper is renowned for signature programs in cardiology, cancer, critical care, pediatrics, trauma, orthopaedics and neurosciences. Cooper is also home to the only state designated Children's Hospital in South Jersey-The Children's Regional Hospital at Cooper. Over the last decade, Cooper has transformed its Camden City neighborhood into the Cooper Health Sciences Campus. In October 2013, the new MD Anderson Cancer Center at Cooper, a free standing cancer center for comprehensive care, opened on the Health Sciences Campus. Cooper also continues its regional expansion with the opening of new and expanded facilities throughout Camden, Burlington and Gloucester Counties.
SOURCE Cooper University Health Care
